Conclusions In conclusion, we believe that circulating EPCs may h

Conclusions In conclusion, we believe that circulating EPCs may have potential as a biomarker for monitoring tumor progression and angiogenesis. Acknowledgements The study was supported in part by the this website Ministry of Health research funds of China (No. WKJ2007-3-001) and the Provincial

Natural Science Foundation (No. 07300312). References 1. Roett MA, Evans P: Ovarian cancer: an overview. Am Fam Physician 2009,80(6):609–616.PubMed 2. Banerjee S, Gore M: The future of targeted therapies in ovarian cancer. Oncologist 2009,14(7):706–716.PubMedCrossRef 3. Spannuth WA, Sood AK, Coleman RL: Angiogenesis as a strategic target for ovarian cancer therapy. Nat Clin Pract Oncol 2008,5(4):194–204.PubMedCrossRef 4. Nico B, Benagiano V, Mangieri D, Maruotti N, Vacca A, Ribatti D: Evaluation of microvascular density in tumors: pro and contra. Histol Histopatho 2008,23(5):601–607. 5. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V: Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis. Science 2008,319(5860):195–198.PubMedCrossRef INK 128 supplier 6. Ding YT, Kumar S, Yu DC: The role of endothelial progenitor cells in tumour vasculogenesis. Pathobiology 2008,75(5):265–273.PubMedCrossRef 7. Gao D, Nolan D, McDonnell K, Vahdat L, Benezra R, Altorki N, Mittal V: Bone marrow-derived endothelial progenitor cells contribute

to the angiogenic switch in tumor growth and metastatic progression. Biochim

Biophys Acta 2009,1796(1):33–40.PubMed 8. Shaked Yuval, Ciarrocchi Alessia, Franco Marcela, Lee ChristinaR, Man Shan, Cheung AlisonM, Hicklin DanielJ, Chaplin David, Foster StuartF, Benezra Robert, Kerbel RobertS: Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors. from Science 2006,313(5794):1785–1787.PubMedCrossRef 9. Chane J, Wang H, Cheu W, Huang S, Liu M, Hsioh J, Yoh K: Identification and Clinical Significance of Circulating Endothelial Progenitor Cells in Human Non-Small Cell Lung Cancer. Cancer Res 2006,66(14):7341–7347.CrossRef 10. Ho JW, Pang RW, Lau C, Sun CK, Yu WC, Fan ST, Poon RT: Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 2006,44(4):836–843.PubMedCrossRef 11. Christiane Richter-Ehrenstein C, Rentzsch J, Runkel S, Schneider A, Schönfelder G: Endothelial progenitor cells in breast cancer patients. Breast Cancer Res Treat 2007,106(3):343–349.PubMedCrossRef 12. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP: VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006,20(9):1495–1497.PubMedCrossRef 13. Kawamoto A, Asahara T: Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter Cardiovasc Interv 2007,70(4):477–484.PubMedCrossRef 14.

Comments are closed.